Department of Pharmaceuticals intensified monitoring of availability, production and supply of drugs used for Covid-19 Treatment in early April, 2021 as number of cases of Covid-19 started increasing steeply. Remdesivir is a patented drug, manufactured in India under voluntary licenses granted by Gilead Life Sciences USA, the patent holder, to 7 Indian pharmaceutical companies (Cipla, Dr Reddy’s Lab., Hetero, Jubilant… Continue reading "Substantial increase in number of manufacturing sites of Remdesivir"
The Centre has decided to increase production of anti-viral drug Remdesivir and it will be provided to people at government’s price, said Union Minister Nitin Gadkari on Thursday. This comes after several cases of black-marketing of Remdesivir came to light amid the COVID-19 pandemic. “There was a shortage of Remdesivir injection. Because of this, incidents of black marketing took place.… Continue reading "Central government to increase production of Remdesivir"
The production of life-saving Remdesivir injection used for the treatment of COVID-19 patients and is currently in scarcity in the country, will be augmented to 74 lakh units by next month from 38.80 lakh units now, the Home Ministry said. The ministry also asked the states and Union territories (UTs) to ensure seamless supply and transport of Remdesivir. Union Home… Continue reading "Remdesivir production to be augmented to 74 lakh units by June"